BIOMAT Database Logo BIOMAT Database Logo

[Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Evaluation of cephalothin/cephalexin monotherapy as initial treatment]. 1993

M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Odense Sygehus, klinisk mikrobiologisk afdeling og nefrologisk afdeling Y.

To evaluate the initial antibiotic regime of cephalothin monotherapy in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD), the frequency of peritonitis was registered retrospectively together with the frequency of recurrent episodes and change of antibiotic. A median frequency of 0.96 episodes per year of dialysis was found. In 24% of the episodes no microorganism was cultured. 82% of the microorganisms were gram-positive cocci, 17% gram-negative rods. The frequency of recurrent episodes was 7%. The initial antibiotic treatment with cephalothin had to be changed in 33% of the cases due to microbial resistance. In another 33% the antibiotic treatment was changed to something with a narrower spectrum. More than one third of the resistant microorganisms were methicillin-resistant coagulase-negative staphylococci. With quick and reliable microbiological diagnostic technique that makes it possible to change the antibiotic treatment early, we find cephalothin to be a suitable initial monotherapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002512 Cephalothin A cephalosporin antibiotic. Cefalotin,Sodium Cephalothin,Cefalotina Normon,Cefalotina Sodica Spaly,Ceftina,Cephalothin Monosodium Salt,Keflin,Seffin,Cephalothin, Sodium,Monosodium Salt, Cephalothin,Salt, Cephalothin Monosodium
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females

Related Publications

M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
February 1990, Clinical pharmacy,
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
February 1988, British journal of clinical practice. Supplement,
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Treatment of fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
June 1990, The American journal of medicine,
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
January 1985, American journal of diseases of children (1960),
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
May 1983, Pediatrics,
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Post-transplant peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
May 1987, The Journal of hospital infection,
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
[Eosinophilic peritonitis in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)].
August 1985, Ugeskrift for laeger,
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
August 1983, The American journal of medicine,
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis.
January 1985, European journal of clinical pharmacology,
M K Hornstrup, and T G Nielsen, and B Gahrn-Hansen, and F B Pedersen, and M Klausen
[Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].
April 1996, Ugeskrift for laeger,
Copied contents to your clipboard!